
Travoprost
Travoprost is the isopropyl ester of prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of travoprost are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. It is a pro-drug; the isopropyl ester group is hydrolysed by esterases in the cornea to the biologically active free acid, fluprostenol. It has a role as an antihypertensive agent, an antiglaucoma drug, a prodrug, a prostaglandin receptor agonist and an ophthalmology drug. It is an isopropyl ester, a prostaglandins Falpha and a member of (trifluoromethyl)benzenes. It is functionally related to a fluprostenol. — ChEBI
- IUPAC-Name
- propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
- Summenformel
- C26H35F3O6
- Molekulargewicht
- 500.5 g/mol
- Exakte Masse
- 500.23857332 Da
- XLogP3
- 4,1
- Topologische polare Oberfläche
- 96,2 Ų
- Wasserstoffbrücken-Donoren
- 3
- Wasserstoffbrücken-Akzeptoren
- 9
- Kovalente Einheiten
- 1
- Definierte Stereozentren
- 5
Auch bekannt als
16 weitere gemeldete Namen
Kennungen in externen Datenbanken
- ChEBI:CHEBI:746859
- ChEMBL:CHEMBL1200799
- EPA DTXSID:DTXSID80896948
- PubMed:19929706
- PubMed:19403113
- PubMed:19038618
- PubMed:18983226
- PubMed:18837686
- PubMed:18452763
- PubMed:15321024
- PubMed:9038626
Am 2026-08-31 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.